Skeletal myoblast based delivery of angiogenic growth factors:a comparison between angiopoietin-1 and VEGF gene delivery for therapeutic angiogenesis in the heart
- Author:
- No author available
- Journal Title:
- JOURNAL OF GERIATRIC CARDIOLOGY
- Issue:
- 3
- DOI:
- No doi available
- Key Word:
- therapeutic angiogenesis;skeletal myoblasts;vascular endothelial growth factor-165;angiopoietin-1;myocardial infarction
Abstract： Objectives This study investigated the efficacy of human skeletal myoblasts (SkM) mediated either human vascular endothelial growth factor-165 (hVEGF165) or angiopoietin-1 (Ang-1) on vascular development and myocardial regional perfusion. Methods A porcine heart model of chronic infarction was created in 28 female swine by coronary artery ligation. The animals were randomized into:(1) group-1, DMEM injected (n=6), (2) group-2, Ad-null transduced SkM transplanted (n=6), (3) group-3, Ad-hVEGF165 transduced SkM transplanted (n=8), and (4) group-4, Ad-Ang-1 transduced SkM (n=8). Three weeks later, 5 ml DMEM containing 3× 108 SkM carrying exogenous genes were intramyocardially injected into 20 sites in left ventricle in groups-2, -3 and -4. Animals in group-1 were injected 5 ml DMEM without cells. Animals were kept on 5 mg/kg cyclosporine per day for 6 weeks. Regional blood flow was measured using fluorescent microspheres. The heart was explanted at 2, 6 and 12 weeks after transplantation for histological studies. Results Histological examination showed survival of lac-z expressing myoblasts in host tissue. Capillary density based on Von Willebrand factor-Ⅷ (vWF-Ⅷ) at low power field (× 100) was 57.13+11.85 in group-3 at 6 weeks and declined to 32.1±5.21 at 12 weeks, while it was 39.9±10.26 at 6 weeks and increased to 45.14±6.54 at 12 weeks in group-4. The mature blood vessel index was highest in group4 at 6 and 12 weeks after transplantation. The regional blood flow in the center and peri-infarct area was significantly increased in animals of groups-3 and -4. Conclusions SkM carrying either hVEGF165 or Ang- 1 induced neovascularization with increased blood flow. Ang- 1 overexpression resulted in mature and stable blood vessel formation and may be a more potent arteriogenic inducer for neovascularization.(J Geriatr Cardiol 2006;3:152-60.)
- [1]Papapetropoulos A,Yancopoulos GD,Maisonpierre PC,etc.Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors.[J].1999,79(2).
- [2]S, Davis,T H, Aldrich,P F, Jones,etc.Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.[J].1996,87(7).
- [3]Rania, Harfouche,Jean-Philippe, Gratton,George D, Yancopoulos,etc.Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases.[J].2003,17.
- [4]Haider KH,Jiang S,Lim YL,etc.Skeletal myoblast transplant in heart failure.[J].2003,18(4).
- [5]James F Symes,Douglas W Losordo,Peter R Vale,etc.Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease[J].1999,68(3).
- [6]T K, Rosengart,L Y, Lee,S R, Patel,etc.Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.[J].1999,100.
- [7]Lei, Ye,Husnain Kh, Haider,Shujia, Jiang,etc.Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model.[J].2005,7(6).
- [8]B, Schumacher,P, Pecher,B U, von Specht,etc.Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.[J].1998,97.
- [9]Lei, Ye,Husnain Kh, Haider,Shujia, Jiang,etc.High efficiency transduction of human VEGF165 into human skeletal myoblasts: in vitro studies.[J].2003,35.
- [10]C, Suri,J, McClain,G, Thurston,etc.Increased vascularization in mice overexpressing angiopoietin-1.[J].1998,282.
- [11]Kwak HJ,Uhm CS,Koh KN,etc.Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting.[J].1999,274(37).
- [12]Ye Lei,HusnainKh Haider,Jiang ShujiaEugeneSK Sim.Therapeutic angiogenesis[J].2004,99(2).
- [13]G, Thurston,C, Suri,K, Smith,etc.Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.[J].1999,286.
- [14]Risau W.,Weiss C.,Deutsch U.,etc.Angiopoietin-1 induces sprouting angiogenesis in vitro[J].1998,8(9).
- [15]Sim EK,Haider HKh,Aziz S,etc.Myoblast transplantation for cardiac repair: a clinical perspective.[J].2004,9(1).
- [16]K, Suzuki,B, Murtuza,R T, Smolenski,etc.Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts.[J].2001,104(12 Suppl 1).
- [17]Raffi, Gurunluoglu,Przemyslaw, Lubiatowski,Corey K, Goldman,etc.Enhancement of muscle flap hemodynamics by angiopoietin-1.[J].2002,48.
- [18]Sim EK,Haider HKh,Ye L,etc.In Vitro Functional Assessment of Human Skeletal Myoblasts After Transduction With Adenoviral Bicistronic Vector Carrying Human VEGF(165) and Angiopoietin-1.[J].2005,24(9).
- [19]Ashraf M,Haider HKh.Bone marrow stem cell transplantation for cardiac repair.[J].2005,288(6).
- [20]Maisonpierre PC,Jones P,Isner JM,etc.Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2.[J].1998,273(29).
- [21]K G, Shyu,O, Manor,M, Magner,etc.Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb.[J].1998,98.
- [22]Sim EK,Haider HKh,Ye L.Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells.[J].2006,231(1).